Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Jul 06, 2005
New Government Sponsored Research Points to Gene Malfunction in Chronic Fatigue Syndrome (CFS)
May 16, 2005
Alferon LDO Now in Human Clinical Trials As Experimental Antiviral/Immunodulatory Therapy
May 16, 2005
Alferon LDO Now in Human Clinical Trials As Experimental Antiviral/Immunodulatory Therapy
May 11, 2005
HEMISPHERX BIOPHARMA FIRST QUARTER 2005 EARNINGS ANNOUNCED
May 03, 2005
Chronic Fatigue Syndrome Presented at Symposium in New York
Apr 11, 2005
Hemispherx Biopharma's Investigational Drug Increases Physical Performance in New Chronic Fatigue Syndrome (CFS) Clinical Study
Mar 30, 2005
Hemispherx Biopharma to Present New Phase III Results in Chronic Fatigue Syndrome Treatment at 18th International Conference on Antiviral Research
Mar 21, 2005
Hemispherx Biopharma Inc. Appoints Steven D. Spence to the Board of Directors
Feb 24, 2005
Hemispherx Biopharma's Alferon N® Highlighted as Potential New Therapy for Avian Influenza on CNBC's "Closing Bell"
Feb 14, 2005
HEMISPHERX BIOPHARMA, INC. ELECTS PRESIDENT AND CHIEF OPERATING OFFICER
56
57
58
59
60
61
62
63
64
65
66
<<
<
>
>>
Privacy